Balamapimod (MKI-833)

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 201922

CAS#: 863029-99-6

Description: Balamapimod, also known as MKI-822, is a Ras/Raf/MEK inhibitor. Balamapimod, may be potentially useful for the treatment or inhibition of certain diseases that are the result of deregulation of Ras/Raf/MEK protein kinases. In addition, Balamapimod may be also useful for the treatment and inhibition of stroke, osteoporosis, rheumatoid arthritis and other inflammatory disorders, as well as polycystic kidney disease and colonic polyps.


Chemical Structure

img
Balamapimod (MKI-833)
CAS# 863029-99-6

Theoretical Analysis

MedKoo Cat#: 201922
Name: Balamapimod (MKI-833)
CAS#: 863029-99-6
Chemical Formula: C30H32ClN7OS
Exact Mass: 573.20776
Molecular Weight: 574.14
Elemental Analysis: C, 62.76; H, 5.62; Cl, 6.17; N, 17.08; O, 2.79; S, 5.58

Size Price Shipping out time Quantity
Inquire bulk and customized quantity

Pricing updated 2021-02-25. Prices are subject to change without notice.

MKI-833, purity > 98%, is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.

Synonym: MKI-833; MKI 833; MKI833; Balamapimod

IUPAC/Chemical Name: 4-((3-chloro-4-((1-methyl-1H-imidazol-2-yl)thio)phenyl)amino)-6-methoxy-7-(4-(pyrrolidin-1-yl)piperidin-1-yl)quinoline-3-carbonitrile

InChi Key: CVAKNHIXTWLGJO-UHFFFAOYSA-N

InChi Code: InChI=1S/C30H32ClN7OS/c1-36-14-9-33-30(36)40-28-6-5-21(15-24(28)31)35-29-20(18-32)19-34-25-17-26(27(39-2)16-23(25)29)38-12-7-22(8-13-38)37-10-3-4-11-37/h5-6,9,14-17,19,22H,3-4,7-8,10-13H2,1-2H3,(H,34,35)

SMILES Code: N#CC1=C(NC2=CC=C(SC3=NC=CN3C)C(Cl)=C2)C4=CC(OC)=C(N5CCC(N6CCCC6)CC5)C=C4N=C1

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not soluble in water.

Shelf Life:
>5 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001

Handling Instructions:

Preparing Stock Solutions

The following data is based on the product molecular weight 574.14 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1. Olszewski, John D.; Berger, Dan M.; May, Michael K. Carbon-14 labelling of 3-cyanoquinolines. Journal of Labelled Compounds and Radiopharmaceuticals (2007), 50(5-6), 578-579. CODEN: JLCRD4 ISSN:0362-4803. CAN 149:128783 AN 2007:1003855 CAPLUS

2. Olszewski, John David; May, Michael K.; Berger, Dan Maarten. Process for preparation of radiolabeled 3-cyanoquinoline derivatives. U.S. Pat. Appl. Publ. (2007), 29pp. CODEN: USXXCO US 2007208164 A1 20070906 CAN 147:322859 AN 2007:993243 CAPLUS

3. Berger, Dan Maarten; Powell, Dennis William; Wu, Biqi. Preparation of 3-quinolinecarbonitrile protein kinase inhibitors for treating various diseases. U.S. Pat. Appl. Publ. (2005), 42 pp. CODEN: USXXCO US 2005187247 A1 20050825 CAN 143:248299 AN 2005:904344 CAPLUS.



Additional Information